142 related articles for article (PubMed ID: 9925657)
1. Presecretory degradation of apolipoprotein [a] is mediated by the proteasome pathway.
White AL; Guerra B; Wang J; Lanford RE
J Lipid Res; 1999 Feb; 40(2):275-86. PubMed ID: 9925657
[TBL] [Abstract][Full Text] [Related]
2. Proteasome inhibition leads to a heat-shock response, induction of endoplasmic reticulum chaperones, and thermotolerance.
Bush KT; Goldberg AL; Nigam SK
J Biol Chem; 1997 Apr; 272(14):9086-92. PubMed ID: 9083035
[TBL] [Abstract][Full Text] [Related]
3. The proteasome participates in degradation of mutant alpha 1-antitrypsin Z in the endoplasmic reticulum of hepatoma-derived hepatocytes.
Teckman JH; Burrows J; Hidvegi T; Schmidt B; Hale PD; Perlmutter DH
J Biol Chem; 2001 Nov; 276(48):44865-72. PubMed ID: 11577074
[TBL] [Abstract][Full Text] [Related]
4. Role of calnexin, calreticulin, and endoplasmic reticulum mannosidase I in apolipoprotein(a) intracellular targeting.
Wang J; White AL
Biochemistry; 2000 Aug; 39(30):8993-9000. PubMed ID: 10913312
[TBL] [Abstract][Full Text] [Related]
5. CD4 glycoprotein degradation induced by human immunodeficiency virus type 1 Vpu protein requires the function of proteasomes and the ubiquitin-conjugating pathway.
Schubert U; Antón LC; Bacík I; Cox JH; Bour S; Bennink JR; Orlowski M; Strebel K; Yewdell JW
J Virol; 1998 Mar; 72(3):2280-8. PubMed ID: 9499087
[TBL] [Abstract][Full Text] [Related]
6. Degradation of a mutant secretory protein, alpha1-antitrypsin Z, in the endoplasmic reticulum requires proteasome activity.
Qu D; Teckman JH; Omura S; Perlmutter DH
J Biol Chem; 1996 Sep; 271(37):22791-5. PubMed ID: 8798455
[TBL] [Abstract][Full Text] [Related]
7. Proteasome-mediated degradation of apolipoprotein B targets both nascent peptides cotranslationally before translocation and full-length apolipoprotein B after translocation into the endoplasmic reticulum.
Liao W; Yeung SC; Chan L
J Biol Chem; 1998 Oct; 273(42):27225-30. PubMed ID: 9765244
[TBL] [Abstract][Full Text] [Related]
8. Effects of tocotrienol on the intracellular translocation and degradation of apolipoprotein B: possible involvement of a proteasome independent pathway.
Wang Q; Theriault A; Gapor A; Adeli K
Biochem Biophys Res Commun; 1998 May; 246(3):640-3. PubMed ID: 9618265
[TBL] [Abstract][Full Text] [Related]
9. Ubiquitin-proteasome pathway mediates intracellular degradation of apolipoprotein B.
Yeung SJ; Chen SH; Chan L
Biochemistry; 1996 Oct; 35(43):13843-8. PubMed ID: 8901527
[TBL] [Abstract][Full Text] [Related]
10. Synphilin-1 degradation by the ubiquitin-proteasome pathway and effects on cell survival.
Lee G; Junn E; Tanaka M; Kim YM; Mouradian MM
J Neurochem; 2002 Oct; 83(2):346-52. PubMed ID: 12423244
[TBL] [Abstract][Full Text] [Related]
11. Chaperone interactions of the metalloproteinase meprin A in the secretory or proteasomal-degradative pathway.
Tsukuba T; Kadowaki T; Hengst JA; Bond JS
Arch Biochem Biophys; 2002 Jan; 397(2):191-8. PubMed ID: 11795871
[TBL] [Abstract][Full Text] [Related]
12. Intracellular maturation of apolipoprotein[a] and assembly of lipoprotein[a] in primary baboon hepatocytes.
White AL; Rainwater DL; Lanford RE
J Lipid Res; 1993 Mar; 34(3):509-17. PubMed ID: 8468534
[TBL] [Abstract][Full Text] [Related]
13. Ubiquitin-dependent and -independent proteasomal degradation of apoB associated with endoplasmic reticulum and Golgi apparatus, respectively, in HepG2 cells.
Liao W; Chang BH; Mancini M; Chan L
J Cell Biochem; 2003 Aug; 89(5):1019-29. PubMed ID: 12874835
[TBL] [Abstract][Full Text] [Related]
14. The effect of the proteasome inhibitor lactacystin on the presentation of transporter associated with antigen processing (TAP)-dependent and TAP-independent peptide epitopes by class I molecules.
Bai A; Forman J
J Immunol; 1997 Sep; 159(5):2139-46. PubMed ID: 9278300
[TBL] [Abstract][Full Text] [Related]
15. Intracellular degradation of secretion defect-type mutants of antithrombin is inhibited by proteasomal inhibitors.
Tokunaga F; Shirotani H; Hara K; Kozuki D; Omura S; Koide T
FEBS Lett; 1997 Jul; 412(1):65-9. PubMed ID: 9257691
[TBL] [Abstract][Full Text] [Related]
16. Degradation of trafficking-defective long QT syndrome type II mutant channels by the ubiquitin-proteasome pathway.
Gong Q; Keeney DR; Molinari M; Zhou Z
J Biol Chem; 2005 May; 280(19):19419-25. PubMed ID: 15760896
[TBL] [Abstract][Full Text] [Related]
17. Ubiquitination is required for the retro-translocation of a short-lived luminal endoplasmic reticulum glycoprotein to the cytosol for degradation by the proteasome.
de Virgilio M; Weninger H; Ivessa NE
J Biol Chem; 1998 Apr; 273(16):9734-43. PubMed ID: 9545309
[TBL] [Abstract][Full Text] [Related]
18. Liver alcohol dehydrogenase is degraded by the ubiquitin-proteasome pathway.
Mezey E; Rennie-Tankersley L; Potter JJ
Biochem Biophys Res Commun; 2001 Jul; 285(3):644-8. PubMed ID: 11453641
[TBL] [Abstract][Full Text] [Related]
19. Inhibition of N-linked glycosylation results in retention of intracellular apo[a] in hepatoma cells, although nonglycosylated and immature forms of apolipoprotein[a] are competent to associate with apolipoprotein B-100 in vitro.
Bonen DK; Nassir F; Hausman AM; Davidson NO
J Lipid Res; 1998 Aug; 39(8):1629-40. PubMed ID: 9717723
[TBL] [Abstract][Full Text] [Related]
20. 6-Aminohexanoic acid as a chemical chaperone for apolipoprotein(a).
Wang J; White AL
J Biol Chem; 1999 Apr; 274(18):12883-9. PubMed ID: 10212277
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
